can lead to strong efficacy, an extended length in plasma or even the focus on tissues may contribute to strong efficacy. As talked over through the Xenon/Genentech team,one zero one compounds with sharp PK profiles (high blood amount peaks) would lead to in vivo Nevertheless, the review results